Showing results (251-260 of 266) with videos related to
Sort By:
Pageof 27
The Lancet. Microbe|July 10, 2020
Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance studyShannon C Duffy, Sreenidhi Srinivasan, Megan A Schilling, et al.Journal of Immunological Methods|August 9, 2011
Single molecule measurements of tumor necrosis factor α and interleukin-6 in the plasma of patients with Crohn's diseaseLinan Song, David W Hanlon, Lei Chang, et al.Chemmedchem|February 2, 2019
Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive BacteriaKyla M Frohlich, Spencer F Weintraub, Janeen T Bell, et al.Journal of Laboratory Automation|June 17, 2015
The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and MultiplexingDavid H Wilson, David M Rissin, Cheuk W Kan, et al.Plos One|December 24, 2011
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humansHenrik Zetterberg, Erik Mörtberg, Linan Song, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.Analytical Chemistry|January 16, 2020
Direct Detection of miR-122 in Hepatotoxicity Using Dynamic Chemical Labeling Overcomes Stability and isomiR ChallengesBarbara López-Longarela, Emma E Morrison, John D Tranter, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 27, 2025
Current challenges in intrauterine management of obstructive fetal hydrocephalus and future directionsS Qaderi, W T Northam, S Duru, et al.Bipolar Disorders|September 4, 2019
An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorderGianni L Faedda, Ross J Baldessarini, Ciro Marangoni, et al.Journal of Medicinal Chemistry|March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitorsJohn Wityak, Kevin F McGee, Michael P Conlon, et al.Pageof 27